Anchen Pharmaceuticals, Inc., headquartered in Irvine, California, is a specialty pharmaceutical company focused on the development and commercialization of extended release and niche generic products. Anchen's mission is to utilize its aggressive Research and Development efforts along with manufacturing and marketing expertise to make available high quality generic products to patients in the US. Anchen takes pride in its creativity and speed in filling Abbreviated New Drug Applications (ANDAs) containing so called "Paragraph IV" certifications, which seek FDA approval to market generic drugs that avoid patents covering branded products. This creativity and speed is one of the key components to Anchen's corporate culture, current and future success.